Moxifloxacin Tablets Shortage

• • Moxifloxacin hydrochloride oral tablet, Major, 400 mg, unit-dose blister pack, 30 count, NDC 00904-6406-04
  • Moxifloxacin hydrochloride oral tablet, Major, 400 mg, unit-dose blister pack, 50 count, NDC 00904-6406-06
  • Moxifloxacin hydrochloride oral tablet, Rising Pharmaceuticals, 400 mg, bottle, 30 count, NDC 57237-0156-30
  • Moxifloxacin hydrochloride oral tablet, Teva, 400 mg, bottle, 30 count, NDC 00093-7387-56

• • Major did not provide a reason for the shortage.
  • Rising did not provide a reason for the shortage.
  • Teva did not provide a reason for the shortage.
  • Aurobindo refuses to provide availability information.

• • There is insufficient supply for usual ordering

Estimated Resupply Dates

• • Major has moxifloxacin 400 mg tablets in 30 count and 50 count unit-dose packages on back order and the company cannot estimate a release date.
  • Rising has moxifloxacin 400 mg tablets in 30 count bottles on intermittent back order and the company is releasing supplies as they become available.
  • Teva has moxifloxacin 400 mg tablets in 30 count bottles on back order and the company cannot estimate a release date.